Cargando…

Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy

BACKGROUND: Doxorubicin (Dox) is a chemotherapy drug with limited application due to cardiotoxicity that may progress to heart failure. This study aims to evaluate the role of cardiomyocytes derived from mouse embryonic stem cells (CM-mESCs) in the treatment of Dox-induced cardiomyopathy (DIC) in mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva dos Santos, Danúbia, Brasil, Guilherme Visconde, Ramos, Isalira Peroba Rezende, Mesquita, Fernanda Cristina Paccola, Kasai-Brunswick, Tais Hanae, Christie, Michelle Lopes Araújo, Cahli, Gustavo Monnerat, Barbosa, Raiana Andrade Quintanilha, da Cunha, Sandro Torrentes, Pereira, Jonathas Xavier, Medei, Emiliano, Campos de Carvalho, Antonio Carlos, Carvalho, Adriana Bastos, Goldenberg, Regina Coeli dos Santos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799903/
https://www.ncbi.nlm.nih.gov/pubmed/29402309
http://dx.doi.org/10.1186/s13287-018-0788-2